What leads to severe COVID-19 diseases? Skip to main content

What leads to severe COVID-19 diseases?

01.03.2023

Infection with SARS-CoV-2 leads to severe disease in some people, while others do not get ill or only experience mild disease. But why is this the case? Unfortunately, we do not know exactly. We do know that an overactive innate immune system is causing severe COVID-19 disease, but it is unclear how this is regulated.

A team led by Professor Dr. Yang Li from Hannover Medical School (MHH) has come a step closer to answering this question. They addressed the question to what extent the course of disease is genetically or epigenetically regulated. The team included scientists from the MHH who, like Professor Li, also conduct research in the Cluster of Excellence RESIST.
Image: The photo shows the scanning of a blood sample in a laboratory at CiiM.; Copyright: Karin Kaiser / MHH

MHH research team analyses genetic and epigenetic regulators. The photo shows the scanning of a blood sample in a laboratory at CiiM.

Products and exhibitors related to this topic

Image: Laboratory automaton pipettes samples into microwell plates; Copyright: Messe Düsseldorf
Exhibitors and products related to this topic can be found in the database of MEDICA 2022:

More topic-related exciting news from the editors of MEDICA-tradefair.com

The team was able to identify underlying regulators of the malfunction of the innate immune system in COVID-19. In addition, it was able to confirm that certain already known genetic risk factors play a role in the development of the COVID-19 disease. The results have been published in the journal Cell Genomics. First authors of this publication are Dr Valerie Koeken, Dr Bowen Zhang and Dr Zhenhua Zhang. The research team conducted the study at the Centre for Individualised Infection Medicine (CiiM).

For this study, the team examined individual immune cells from the blood of COVID-19 patients using single-cell multiomics analysis. This technique can be used to simultaneously assess how cells are being regulated and how they are functioning. For this purpose, both the genetic material of the cells is examined and it is analysed if certain parts of the genome are ‘switched on’ (epigenetics) and if genes are being transcribed into ribonucleic acid molecules.

In a specific type of white blood cells (monocytes) whis are overactivated in severe COVID-19 disease, the team was able to identify how altered accessibility to chromatin is regulating gene expression and which transcription factors are steering these dysfunctional monocytes. In addition, they were able to identify how a specific genetic variant is contributing to a higher viral load and an increased risk of needing hospitalisation for COVID-19. This enabled them to identify one of the factors driving increased susceptibility to severe disease in certain individuals. "Overall, our study highlights the multiple genetic and epigenetic regulators that contribute to COVID-19," summarises Prof. Li.

MEDICA-tradefair.com; Source: Medizinische Hochschule Hannover

More about the Medizinische Hochschule Hannover at: www.mhh.de

More about…

Return to top